Profil
F.
Allan Gordon worked as the Chief Executive Officer at Nile Therapeutics, Inc. and as the Medical Director-Scandinavia at Bristol Myers Squibb Co. He also held the position of Senior Director-Clinical Research at Scios, Inc. and Vice President-Clinical at XOMA Corp.
He was the Senior Vice President-Clinical Development at Resverlogix Corp.
for six years.
Additionally, he worked as an Associate Professor at Karolinska Institutet.
Dr. Gordon earned a doctorate degree from Karolinska Institutet.
Anciens postes connus de F. Allan Gordon
| Sociétés | Poste | Fin |
|---|---|---|
| XOMA CORPORATION | Directeur Technique/Scientifique/R&D | 01/08/2017 |
| RESVERLOGIX CORP. | Directeur Technique/Scientifique/R&D | 01/01/2014 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Directeur Technique/Scientifique/R&D | 01/01/2007 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Karolinska Institutet | Corporate Officer/Principal | - |
Formation de F. Allan Gordon
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| XOMA CORPORATION | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Nile Therapeutics, Inc. /Old/ | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |